Table 2 Prognostic factors for the death of PRS patients.

From: Clinical characteristics and prognosis of pulmonary renal syndrome in West China

 

Death (unadjusted)

Death (adjusted)

OR (95% CI)

SE

P value

OR (95% CI)

SE

P value

Sex

0.54 (0.15–1.87)

0.34

0.33

Age

0.99 (0.96–1.03)

0.02

0.66

Duration of prodromal illness

1.04 (0.85–1.27)

0.11

0.68

Fever

1.33 (0.22–8.25)

1.24

0.76

Hemoptysis

2.07 (0.49–8.80)

1.53

0.32

Respiratory failure

6.50 (1.65–25.58)

4.54

0.007

11.76 (1.13–122.31)

14.05

0.04

PAH

2.63 (0.70–9.81)

1.77

0.15

2.41 (0.37–15.81)

2.32

0.36

Initial hemodialysis

0.56 (0.15–2.13)

0.38

0.4

Mechanical ventilation

8.25 (1.69–40.32)

6.68

0.009

0.62 (0.04–10.59)

0.9

0.75

ANCA positive

0.33 (0.06–1.90)

0.3

0.22

anti-GBM antibody positive

4.44 (0.98–20.09)

3.42

0.05

16.32 (1.19–223.52)

21.79

0.04

DAH

0.83 (0.21–3.32)

0.59

0.8

ILD

1.20 (0.30–4.79)

0.85

0.8

Alb

1.00 (0.89–1.14)

0.06

0.95

Scr

1 (1.00–1.002)

0.001

0.65

HBG

0.98 (0.95–1.01)

0.02

0.18

0.96 (0.92–1.004)

0.02

0.07

WBC

0.93 (0.72–1.19)

0.12

0.55

CRP

1.02 (1.00–1.04)

0.01

0.06

1.01 (0.99–1.04)

0.01

0.34

ESRD onset to dialysis

0.31 (0.07–1.28)

0.22

0.11

0.15 (0.02–1.29)

0.16

0.08

  1. Variates of p value <0.2 were enrolled in multivariate analysis. Adjusted for respiratory failure, PAH, mechanical ventilation, anti-GBM antibodies, HBG, CRP and ESRD to dialysis.